发明名称 |
CRYSTALLINE FORMS OF A BIPHENYL COMPOUND |
摘要 |
The invention provides crystalline forms of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester, and pharmaceutically acceptable solvates thereof. The crystalline form can be a freebase, or a salt such as a diphosphate, monosulfate or dioxalate salt. The invention also provides pharmaceutical compositions comprising these crystalline compounds or prepared using these compounds; processes and intermediates for preparing the crystalline compounds; and methods of using these compounds to treat a pulmonary disorder. |
申请公布号 |
US2014288033(A1) |
申请公布日期 |
2014.09.25 |
申请号 |
US201414219296 |
申请日期 |
2014.03.19 |
申请人 |
Axt Sabine;Church Timothy J. |
发明人 |
Axt Sabine;Church Timothy J. |
分类号 |
C07D401/12;A61K45/06;A61M15/00;A61K31/4545 |
主分类号 |
C07D401/12 |
代理机构 |
|
代理人 |
|
主权项 |
1. A crystalline dioxalate salt of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester, characterized by a powder x-ray diffraction pattern comprising diffraction peaks at 2θ values of 8.7±0.2, 14.0±0.2, 19.4±0.2, and 22.9±0.2. |
地址 |
Sunnyvale CA US |